Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.09.2023 · 325 (3) · G239-G250
DOI: 10.1152/ajpgi.00089.2023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.09.2023. Verfasst von Jihane N Benhammou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Vatche and Tamar Manoukian Division of Digestive Diseases, University of California, Los Angeles, California, United States. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Liver Neoplasms, YAP-Signaling Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, HHS | NIH | National Center for Advancing Translational Sciences (NCATS), Foundation for the National Institutes of Health (FNIH).
Abstract (Originalsprache)
Statins are widely used for the treatment of cardiovascular diseases. Recently, their use has been associated with a decrease in the incidence of hepatocellular carcinoma (HCC); however, their mechanism(s) has remained elusive. In this study, we delineate the mechanism by which statins affect the Yes-associated protein (YAP), which has emerged as a key oncogenic pathway in HCC. We investigate each step of the mevalonate pathway and demonstrate that statins regulate YAP via Rho GTPases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vatche and Tamar Manoukian Division of Digestive Diseases, University of California, Los Angeles, California, United States.
- Division of Gastroenterology, Hepatology and Parental Nutrition, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, California, United States.
- Jonsson Comprehensive Cancer Center, University of California, Los Angeles, California, United States.
- Center for Genetic Medicine Research, Childrens National Research Institute, Washington, District of Columbia, United States.
ORCID-Profile: Jihane N Benhammou, James Sinnett-Smith, Enrique Rozengurt
Förderung
- NCI NIH HHS
- HHS | NIH | National Center for Advancing Translational Sciences (NCATS)
- Foundation for the National Institutes of Health (FNIH)
- BLRD VA
- NCATS NIH HHS
- NIAID NIH HHS
- U.S. Department of Veterans Affairs
Zitieren
APA
Benhammou, J. N., Qiao, B., Ko, A., Sinnett-Smith, J., Pisegna, J. R., & Rozengurt, E. (2023). Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton. American Journal of Physiology-Gastrointestinal and Liver Physiology, 325(3), G239-G250. https://doi.org/10.1152/ajpgi.00089.2023
Vancouver
Benhammou JN, Qiao B, Ko A, Sinnett-Smith J, Pisegna JR, Rozengurt E. Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2023;325(3):G239-G250. doi:10.1152/ajpgi.00089.2023
BibTeX
@article{Benhammou2023,
author = {Benhammou, Jihane N and Qiao, Bo and Ko, Arthur and Sinnett-Smith, James and Pisegna, Joseph R and Rozengurt, Enrique},
title = {Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2023},
volume = {325},
number = {3},
pages = {G239--G250},
doi = {10.1152/ajpgi.00089.2023}
}
EUVIMED